DUBLIN, Feb. 22, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/9gl6c4/biomaterials) has announced the addition of the "Biomaterials Market by Type of Material (Metallic, Ceramic, Polymers, Natural Biomaterials) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2020" report to their offering.
The biomaterials market is expected to reach USD 130.57 Billion in 2020 from USD 62.06 Billion in 2015, growing at a CAGR of 16%.
Biomaterials are revolutionizing several facets of preventive and therapeutic healthcare and are being increasingly used in the development of new medical devices, drug delivery systems, replacement technologies, prostheses, tissue repair, and diagnostic techniques. The medical fraternity across the globe has witnessed a radical paradigm shift due to the growing demand, consumption, and prominence of these materials. Biomaterials are the focus of major research efforts across the globe due to the quality-of-life benefits they offer. Incessant research globally for fulfilling the requirement of highly biocompatible products is a pivotal factor that is stimulating the growth of the global biomaterial market. This has led to immense development of metal, ceramic, polymer, and natural biomaterial-based products.
In 2015, the metallic segment is expected to account for the larger share of the global biomaterials market, by type of material, while the cardiovascular segment is expected to account for the largest share of biomaterial market, by application.
In 2015, North America is expected to account for the largest share of the global biomaterials market, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). North America's large share is attributed to biomaterials-based research in the U.S., growing demand for plastic surgeries in the U.S., conferences on biomaterials in the U.S., increase in cancer incidences in the U.S., growing prevalence of cardiovascular diseases in the U.S., and increasing funding and R&D activities for biomaterials in Canada. In the coming years, the biomaterial market is expected to witness the highest growth rate in the Asian region, with emphasis on India, China, and Japan. The high growth in India and China can be attributed rising cosmetic and plastic surgeries in India, lucrative medical device industry and new tax policy in China, growing number of cardiovascular diseases and increasing aging population in China, and biomaterials workshops & conferences in China.
The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, geographic expansion, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global market.
- Royal Dsm
- Basf Se
- Bayer Ag
- Invibio Ltd. (Subsidiary of Victrex Plc)
- Wright Medical Technology, Inc.
- Carpenter Technology Corporation
- Corbion N.V.
- Covalon Technologies Ltd.
- Evonik Industries Ag
- Zimmer Biomet Holdings, Inc. (A Subsidiary of Zimmer Holdings, Inc.)
- Berkeley Advanced Biomaterails, Inc.
- Cam Bioceramics Bv
- Collagen Matrix, Inc. For more information visit http://www.researchandmarkets.com/research/9gl6c4/biomaterials
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets